The Average Cost of Chemotherapy

Is there such a thing as an average cost of chemotherapy? No. Not even close. In order for there to be an average cost of chemotherapy, one would need an 'average' cancer diagnosis. Every cancer diagnosed everywhere every day in the world is a unique, heterogeneous disease.

Put another way, no two cancers are exactly alike. Just like no two hospital bills are exactly alike, even for the same procedures. Therefore it's hardly surprising that, after a cursory search of the internet, the most interesting and likely most accurate estimate of the average cost of chemotherapy comes from a site called costhelper.com, which offers the following average for patients who are not covered by insurance: between $10,000 and $200,000.

Factors That Determine Cost in Chemotherapy Treatment

There are so many factors to consider when determining what might be the average cost of chemotherapy, it's almost overwhelming:

What Kind of Cancer is Diagnosed

This is the most important determining factor since clinical practice guidelines for cancers vary widely. People diagnosed with a cutaneous lymphoma may only pay a couple of hundred dollars for a topical chemotherapy cream, while those diagnosed with chronic myeloid leukemia might pay $4,000 every month until the drug that treats CML comes off-patent and is available in generic form, at which time cost could drop by 90 percent.

The issue comes down to whether or not the most commonly used drugs to treat cancer X or cancer Y are available in generic form, or if they are not yet off patent.

Where Treatment is Administered

The chemotherapy drugs administered for anticancer treatments originated at the manufacturing facilities of pharmaceutical companies. The facility administering treatment had to first purchase the chemotherapy drugs from the manufacturer, a cost they will pass on to the patient.

At for-profit medical facilities, such as private practices, or medical centers like the Cancer Treatment Centers of America, patients should expect to pay a so-called 'chemotherapy concession'. This is the amount that the facility has added to the wholesale cost of the drug; it could be four percent or forty percent. You'll probably never know, and finding out would consume more time than it's probably worth.

What Complications Are Experienced

You simply can't estimate the cost of chemotherapy without including the costs of the treatments needed for the additional ailments caused by the administration of chemotherapy. This self-feeding industry is such that adverse events from treatment require their own treatments—this might include a dangerous depletion of white blood cells, which could lead to febrile neutropenia, a life-threatening condition that requires a white blood cell booster such as Neulasta. Each injection of Neulasta can cost at least $3,000.

Don't Forget All Those Other Charges

If a patient has insurance, the average cost of chemotherapy does come down considerably. But all patients will be confronted with out-of-pocket costs that they could never have even dreamed of planning for: transportation and meal costs to and from treatment; lab fees; IV administration fees; costs for all the equipment used on you; blood tests; bone scans; MRIs; CT scans; office visit co-pays; money spent on books to cope with chemotherapy; follow-up visits; costs of anti-nausea medications to hold back the urge to vomit from chemotherapy; and on and on and on.

Source: Cost Helper Health
Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap